| Mr Gary H Chandler, CRNA | |
|
200 State Highway 30 W, New Albany, MS 38652-3112 | |
| (662) 538-2370 | |
| Not Available |
| Full Name | Mr Gary H Chandler |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 23 Years |
| Location | 200 State Highway 30 W, New Albany, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386732154 | NPI | - | NPPES |
| 00125903 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R743486 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Mississippi Medical Center- Grenada | Grenada, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Willow Anesthesia Services, Llc | 9234279183 | 28 |
News Archive
As Pete Buttigieg gained momentum in the Democratic presidential primary race - finishing second in the New Hampshire primary and a front runner in the Iowa caucuses - he has increasingly been on the receiving end of shade from his rivals.
"Millions of people in Africa's turbulent Sahel region are on the brink of starvation due to drought and conflict, the United Nations said on Wednesday, and aid response plans are less than 40 percent funded ahead of an expected crisis peak," Reuters reports.
MedAptus today announced that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. The initial version focuses on the Medicare Advantage (MA) patient population where premiums paid to MA health plans are based on enrollees' severity history using the Centers for Medicare and Medicaid Services Hierarchical Condition Categories (HCC) model.
HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS.
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
› Verified 5 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
As Pete Buttigieg gained momentum in the Democratic presidential primary race - finishing second in the New Hampshire primary and a front runner in the Iowa caucuses - he has increasingly been on the receiving end of shade from his rivals.
"Millions of people in Africa's turbulent Sahel region are on the brink of starvation due to drought and conflict, the United Nations said on Wednesday, and aid response plans are less than 40 percent funded ahead of an expected crisis peak," Reuters reports.
MedAptus today announced that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. The initial version focuses on the Medicare Advantage (MA) patient population where premiums paid to MA health plans are based on enrollees' severity history using the Centers for Medicare and Medicaid Services Hierarchical Condition Categories (HCC) model.
HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS.
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
› Verified 5 days ago
| Entity Name | Willow Anesthesia Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205169521 PECOS PAC ID: 9234279183 Enrollment ID: O20091228000308 |
News Archive
As Pete Buttigieg gained momentum in the Democratic presidential primary race - finishing second in the New Hampshire primary and a front runner in the Iowa caucuses - he has increasingly been on the receiving end of shade from his rivals.
"Millions of people in Africa's turbulent Sahel region are on the brink of starvation due to drought and conflict, the United Nations said on Wednesday, and aid response plans are less than 40 percent funded ahead of an expected crisis peak," Reuters reports.
MedAptus today announced that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. The initial version focuses on the Medicare Advantage (MA) patient population where premiums paid to MA health plans are based on enrollees' severity history using the Centers for Medicare and Medicaid Services Hierarchical Condition Categories (HCC) model.
HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS.
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
› Verified 5 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831520691 PECOS PAC ID: 1850293036 Enrollment ID: O20140305001658 |
News Archive
As Pete Buttigieg gained momentum in the Democratic presidential primary race - finishing second in the New Hampshire primary and a front runner in the Iowa caucuses - he has increasingly been on the receiving end of shade from his rivals.
"Millions of people in Africa's turbulent Sahel region are on the brink of starvation due to drought and conflict, the United Nations said on Wednesday, and aid response plans are less than 40 percent funded ahead of an expected crisis peak," Reuters reports.
MedAptus today announced that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. The initial version focuses on the Medicare Advantage (MA) patient population where premiums paid to MA health plans are based on enrollees' severity history using the Centers for Medicare and Medicaid Services Hierarchical Condition Categories (HCC) model.
HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS.
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
› Verified 5 days ago
| Entity Name | Boa Vida Hospital Of Aberdeen Ms Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710405741 PECOS PAC ID: 0244505840 Enrollment ID: O20171128003460 |
News Archive
As Pete Buttigieg gained momentum in the Democratic presidential primary race - finishing second in the New Hampshire primary and a front runner in the Iowa caucuses - he has increasingly been on the receiving end of shade from his rivals.
"Millions of people in Africa's turbulent Sahel region are on the brink of starvation due to drought and conflict, the United Nations said on Wednesday, and aid response plans are less than 40 percent funded ahead of an expected crisis peak," Reuters reports.
MedAptus today announced that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. The initial version focuses on the Medicare Advantage (MA) patient population where premiums paid to MA health plans are based on enrollees' severity history using the Centers for Medicare and Medicaid Services Hierarchical Condition Categories (HCC) model.
HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS.
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Gary H Chandler, CRNA 4810 Stonebridge Cv, Tupelo, MS 38801-9499 Ph: (662) 841-2858 | Mr Gary H Chandler, CRNA 200 State Highway 30 W, New Albany, MS 38652-3112 Ph: (662) 538-2370 |
News Archive
As Pete Buttigieg gained momentum in the Democratic presidential primary race - finishing second in the New Hampshire primary and a front runner in the Iowa caucuses - he has increasingly been on the receiving end of shade from his rivals.
"Millions of people in Africa's turbulent Sahel region are on the brink of starvation due to drought and conflict, the United Nations said on Wednesday, and aid response plans are less than 40 percent funded ahead of an expected crisis peak," Reuters reports.
MedAptus today announced that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. The initial version focuses on the Medicare Advantage (MA) patient population where premiums paid to MA health plans are based on enrollees' severity history using the Centers for Medicare and Medicaid Services Hierarchical Condition Categories (HCC) model.
HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS.
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
› Verified 5 days ago
Calley Dunn, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1342 County Road 94, New Albany, MS 38652 Phone: 662-202-7277 | |
James Bailey, CRNA, DNP Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 200 State Highway 30 W, New Albany, MS 38652 Phone: 662-538-7631 | |
Mrs. Cheryl A Sanders, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 State Highway 30 W, New Albany, MS 38652 Phone: 662-538-2370 | |
Mr. Christopher Alan Henthorne, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 State Highway 30 W, New Albany, MS 38652 Phone: 662-538-2370 | |
Mrs. Summer Audra Palmer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Hwy 30 W, New Albany, MS 38652 Phone: 662-538-2370 |